Get a reply from this employer — a resume and cover letter tailored to exactly what they’re hiring for.
Celcuity is seeking a Senior Manager / Associate Director, Commercial Supply Operations to establish and manage a robust global supply chain for commercial Gedatolisib and future programs. The role supports development of processes ensuring continuous commercial supply while maintaining regulatory and quality compliance.
The position will oversee production planning, logistics, warehousing, procurement, demand management, and end-to-end inventory strategy, including compliance with DSCSA and
The Senior Manager / Associate Director, Commercial Supply Operations, will support the establishment and management of a robust and effective global supply chain to support commercial supply of gedatolisib and future pipeline programs. This position will have a critical role in realizing the vision for Celcuity's commercial manufacturing organization by supporting the development and maintenance of processes to ensure continuous commercial supply while maintaining regulatory and quality compliance.
This role will support production planning, global logistics and warehousing, global supply chain procurement, planning and sourcing, demand management, end-to-end inventory strategy and materials management, global trade compliance, security and integrity and packaging. This role will also support the development and implementation of the standard business processes, including quality-related activities, to support the launch of new products; business integrations and subsequent supply operations for both internally and at CMO partners.
Celcuity is an Equal-Opportunity Employer.
Celcuity is committed to fair and equitable compensation practices, and we strive to provide employees with total compensation packages that are competitive. For this role, the anticipated base pay range is $150,000 - $190,000 DOE. The exact base pay offered for this role will depend on various factors, including but not limited to the candidate's geography, qualifications, skills, and experience.
Celcuity also offers various benefits offerings, including, but not limited to, medical, dental, vision insurance, 401(k) match, PTO, and paid holidays.
Celcuity is a commercial biotechnology company pursuing development of targeted therapies for treatment of multiple solid tumor indications. The company's first FDA-approved product is REVTORPYK (gedatolisib), a potent, pan-PI3K and mTORC1/2 inhibitor that comprehensively blockades the PAM pathway. REVTORPYK is approved to treat adults with HR+/HER2- advanced breast cancer that progressed on prior endocrine therapy in the metastatic setting.
The Phase 3 VIKTORIA-2 trial is evaluating gedatolisib in combination with palbociclib and either fulvestrant or letrozole for the first-line treatment of HR+/HER2- locally advanced or metastatic breast cancer. A Phase 1/2 clinical trial evaluating gedatolisib in combination with darolutamide in patients with metastatic castration resistant prostate cancer, is ongoing.